Long-Term Persistence Follow-up Study to Evaluate the Immune Persistence of GSK Biologicals' Combined Hepatitis A / Hepatitis B Vaccine in Healthy Children
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2018
At a glance
- Drugs Hepatitis A-hepatitis B vaccine (Primary) ; Hepatitis B vaccine recombinant
- Indications Hepatitis A; Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
- Sponsors GlaxoSmithKline
- 26 Feb 2009 Actual patient numbers (178) added as reported by ClinicalTrials.gov.
- 26 Jul 2008 New trial record.